Research & sustainability
The pharmaceutical and biotechnology sectors in Cuxhaven are key pillars of the regional economy. In total, the industry provides around 1,000 jobs.
The waterfront location offers advantages—and not just in terms of quality of life. Sustainable developments in marine resource use also hold the promise of new opportunities.
Pharmaceutical biotechnology combines biological processes with drug development to produce innovative therapies, vaccines, and diagnostics. While traditional pharmaceutical companies rely on chemical synthesis, biotech firms use living cells (red biotechnology) to produce complex active ingredients. This intersection serves as a key driver of innovation for modern medicine, cell therapies, and stem cell research.
In Cuxhaven alone, several companies in the biotechnology and pharmaceutical sectors are engaged in what is known as “red biotechnology.” They rank among the most successful companies in their industry, are heavily invested in research, and are globally connected through international collaborations.
“Red biotechnology” refers to the branch of medicine that focuses on applications in the field of health (red stands for the color of blood).
The portfolio of pharmaceutical and biotechnology companies includes not only the manufacture of human pharmaceutical products and generics for the cardiovascular, metabolic, urological, and neurological fields, but also dental products.
The range of services offered by veterinary medicine companies includes the development and manufacture of vaccines and animal feed for livestock breeding. Furthermore, the maritime character of the regional economy offers interesting prospects for “blue technology.” Significant momentum and synergy effects are expected, particularly in the wake of the growing number of offshore wind farms in the North Sea.
Contact us
Juergen from Ahnen
Agency Manager, Managing Director of the Leader Region Wesermünde-Nord
Tel.: +49 (0) 4721 / 599-716